Environmental Performance: Energy

Energy Program

Each division is required to develop and maintain an energy management program based on the characteristics of its specific operational situations. The Corporate Quality, Environment, Health, and Safety Department reviews these programs annually and reports its findings to senior management. The program objectives are supported by a number of other company initiatives that require consideration of energy issues, including our EHS Policy, acquisition due diligence, Capital Appropriation Request (CAR) review process, and product life cycle assessments. As a result, our new facilities typically make use of state-of-the art, energy-efficient technologies.

Energy Use

Bristol-Myers Squibb collects and reports data on electricity use and fuel usage from our facilities worldwide. For worldwide fuel usage, our facilities track diesel fuel, gasoline, propane, fuel oil, coal, and natural gas. The vast majority of the fuel consumed by our facilities is natural gas, which produces less air pollution than coal or fuel oil. In addition to the fuel used on-site by our facilities (categorized as direct energy use), we also track indirect energy, which includes the electricity purchased by Bristol-Myers Squibb.

Our total energy use (including direct and indirect energy use) decreased 4 percent between 2006 and 2007, or by 11 percent when normalized by sales. This is due in part to our companywide efforts to conserve energy and, thereby, reduce greenhouse gas emissions.

energy chart

The company's Sustainability Goals include reducing energy use by 10 percent, normalized by sales, from a 2001 baseline. From 2001 to 2007, our total energy use decreased by 5 percent, and decreased by 18 percent normalized by sales. We recognize that we must continue to reduce our energy consumption in order to maintain the 2010 goal.

Our direct energy use at our operations decreased by nearly 4 percent from 2006 to 2007, or 11 percent when normalized by sales. Overall, our indirect energy use decreased by 4 percent from 2006 to 2007, and by 11 percent when normalized by sales.

The company participates in voluntary initiatives with regulatory authorities. For example, our facility in Wallingford, Connecticut, is a participant in the U.S. EPA and Department of Energy Labs 21 Program for improving laboratory energy and water efficiency, encouraging the use of renewable energy sources, and promoting environmental stewardship.

Bristol-Myers Squibb Company operates a 1 million square-foot pharmaceutical research and development facility in Wallingford, Connecticut. The site covers 180 acres and houses a state-of-the-art research laboratory. It is staffed by approximately 1,200 employees working to discover cures for diseases such as cancer and HIV. The site requires a significant amount of energy, both electricity and steam. To optimize reliability, efficiency, economics, and environmental performance, Bristol-Myers Squibb constructed and continues to invest in a combined heat and power (CHP) plant that consists of a 4.8-megawatt combustion turbine that uses clean-burning natural gas, and a heat recovery system (waste heat boiler). The efficiency of the CHP system is approximately 72 percent, as compared to an estimated 32 percent efficiency for the entire U.S. electric system. Considering the amount of electric and steam energy that BMS Wallingford draws from its CHP plant and comparing this with the alternative (buying power from the New England power pool and generating steam through a typical boiler), the CHP system has reduced site GHG emissions by approximately 20 percent, or roughly 6,600 tons per year.

Currently, several of our facilities around the world have systems that generate electricity on site, including Hopewell, Lawrenceville, and New Brunswick, New Jersey; Wallingford, Connecticut; Delicias, Mexico; Guayaquil, Ecuador; Karachi, Pakistan; Anagni, Italy; and São Paulo, Brazil. Some of these locations have cogeneration facilities on site. Cogeneration produces electricity plus steam or hot water for site operations using one fuel (typically natural gas), thereby greatly increasing efficiency and decreasing the site's use of purchased electricity.

In 2007, our technical operations plant in Anagni, Italy, installed solar panels over 80 square meters of the facility's rooftop. The system feeds directly into the Italian energy network, which in turn gives the Anagni facility the equivalent amount of energy. This project generates about 57 gigajoules per year and will offset about 9,750 kg of carbon dioxide annually. At the on-site child development center in Hopewell, New Jersey, a solar photovoltaic (renewable energy) system generated more than 475 gigajoules of energy since start-up in late 2004.

In 2007, the total amount of energy generated by Bristol-Myers Squibb facilities on site was nearly 450,000 gigajoules. We also generated over 499 million kilograms of steam by cogeneration and 157 gigajoules through renewable energy sources.

Last updated June 20, 2008 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.